Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis

Patompong Ungprasert1, Prangthip Charoenpong, Praveen Ratanasrimetha

  • 1Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, P.Ungprasert@gmail.com.

Insights

Patients with systemic sclerosis (SSc) face a significantly higher risk of developing coronary artery disease (CAD). This meta-analysis confirms a 1.82 times increased risk, highlighting a critical link between SSc and heart health.

Area of Science:

  • Cardiology
  • Rheumatology
  • Epidemiology

Background:

  • Chronic inflammatory disorders like rheumatoid arthritis and lupus increase coronary artery disease (CAD) risk.
  • The association between systemic sclerosis (SSc) and CAD risk remains unclear.

Purpose of the Study:

  • To systematically review and meta-analyze observational studies assessing CAD risk in patients with SSc.
  • To quantify the pooled risk ratio of CAD in individuals diagnosed with SSc compared to non-SSc individuals.

Main Methods:

  • Systematic review and meta-analysis of observational studies.
  • Inclusion criteria: studies reporting risk estimates (OR, RR, HR, SIR) for CAD in SSc patients.
  • Data synthesis using a random-effects, generic inverse variance method.

Main Results:

  • Four studies were included in the analysis.
  • The pooled risk ratio for CAD in patients with SSc was 1.82 (95% CI, 1.40 to 2.36).
  • Moderate statistical heterogeneity was observed (I² = 73%).

Conclusions:

  • Systemic sclerosis is associated with a statistically significant increased risk of coronary artery disease.
  • Findings underscore the importance of cardiovascular risk assessment in SSc patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
617
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
889
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
726
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K